1[1]Spada A, Vallar L, Faglia G. Cellular alterations in pituitary tumors [J]. Eur J Endocrinol, 1994; 130(1): 43-52.
2[2]Boggild MD, Jenkindon S, Pistorello M, et al. Molecular genetic studies of sporadic pituitary tumors [J]. J Clin Endocrinol Metab, 1994; 78(2): 387-392.
3[3]Tordjman K, Stem N, Ouaknine G, et al. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors [J]. J Clin Endocrinol Metab, 1993; 77(3): 765-769.
4[4]Karga H J, Alexander JM, Hedley-Whyte ET, et al. Ras mutations in human pituitary tumors [J]. J Clin Endocrinol Metab,1992; 74(4): 914-919.
5[5]Suliman M, Royds J, Cullen D, et al. Mdm2 and the p53 pathway in human pituitary adenomas [J]. Clin Endocrinol (Oxf),2001; 54(3): 317-325.
6[6]Pei L, Melmed S, Scheithauer B, et al. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary rumors: evidence for a chromosome 13 rumor suppressor gene other than RB [J]. Cancer Res, 1995;55(8): 1613-1616.
7[7]Alvaro V, Levy L, Dubray C, et al. Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C [J]. J Clin Endocrinol Metab, 1993; 77(5): 1125-1129.
8[8]Faglia G. Epidemiology and pathogenesis of pituitary adenomas [J]. Acta Endocrinol, 1993; 129 (Suppl 1): 1-5.
9[9]Hashimoto K, Nagano I, Asaba K, et al. Significant gene expression of insulin-like growth factor Ⅱ and proliferating cell nuclear antigen in a rapidly growing recurrent pituitary acth-secreting adenoma [J]. Horm Res, 2000; 54(4): 198-202.
10[10]Fraioli B, Esposito V, Palma L, et al. Hemorrhagic pituitary adenomas: clinicopathological features and surgical treatment.Neurosurgery, 1990; 27(5): 741-748.
6NOMIKOS P, BUCHFELDER M, FAHLBUSCH R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical cure[J].Eur J Endocrnol, 2005,152(3): 379-387.
7TREPP R, STETTLER C, ZWAHLEN M, et al. Treatment outcomes and mortality of 94 patients with acromegaly[J]. Acta Neurochir (Wien), 2005,147 (3) : 243-251.
9Swearingen B, Barker FG, Katxnelson L, et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinal Metab, 1998, 83(10): 3419.
